The 34th International Symposium on ALS/MND arrived at a moment of real momentum in ALS research. The field has seen a significant expansion in genetic understa...
Continue reading
As we step into a new era of medical innovation, it's crucial to shine a light on diseases that have long remained in the shadows. Amyotrophic lateral sclerosis...
Continue reading
Families affected by ALS urged to join free program to uncover their genetic risk, contribute to research, and access new therapies Sano Genetics launches ‘Ligh...
Continue reading
ALS remains one of the most challenging neurodegenerative diseases, with limited treatment options and a progressive course that affects motor function, breathi...
Continue reading
In this blog, we're exploring whether ALS can be caught early, including the tests that may be used in order to diagnose ALS, and if there are any measures that...
Continue reading
Our latest insights report explores multiple sclerosis (MS), providing details on the essential aspects of MS, from its impact on the central nervous system to ...
Continue reading
Last month, our team had the pleasure of attending the European Network to Cure ALS (ENCALS) meeting, an annual gathering that brings together some of the brigh...
Continue reading
£330K grant awarded to support and engage patients at risk of MND/ALS, and track the psychological impact of genetic testing.
Continue reading
This webinar, hosted by Paul Wicks and featuring a panel of experts in ALS and genetics, focuses on the challenges and variability in genetic testing and counse...
Continue reading
Mutations in the SOD1 gene were the first identified genetic cause of ALS, discovered in 1993. Yet SOD1-ALS accounts for only approximately 2% of all ALS cases,...
Continue reading